Today on Health in 2 Point 00, we have another takeover edition! On Episode 92, Jess talks to Louise Schaper, CEO of the Health Informatics Society of Australia (HISA) at HIC 2019. Louise’s key takeaway from the conference is that health tech in Australia is focused on humanity and improving outcomes for all people. Jess also asks Louise about the Australian Digital Health Agency’s MyHealthRecord, an online summary of individuals’ health information. It’s got a great participation rate with 90% of Australians opted in, but it’s not being utilized as much as it could be. Finally, Louise debunks some of the chatter around HealthEngine’s data scandal in which they were caught sharing health data with law firms. The thing is, the press has sold it as if they have full access to your medical data and has sold that, but that’s not the case.
By INGA SHUGALO
While the healthcare IoT demand forecasts are more than generous, anticipating the market to hit $158.07B by 2022, there is still a certain delay in IoT adoption across the industry. Connected medical devices, especially those that are directly involved in patient care, are adopted cautiously due to potential security vulnerabilities and risks to patient safety.
One of the reasons behind the hesitant adoption of healthcare IoT in cardiology is preexisting concerns about the security of implantable medical devices, such as pacemakers.
The recent pacemaker crisis revealed the vulnerabilities in pacemaker software across several major vendors. If exploited, software vulnerabilities would allow hackers to take over the device and control it fully. The crisis led to device recalls, certain features disabled, and even remote updates cut off completely to avoid unacceptable health risks.
This series of events led to a cautious attitude toward the emerging cardiology IoT. Since we can’t be sure that all exploits and vulnerabilities are eliminated in less advanced systems, are we really ready to take a step forward to more elaborate healthcare software solutions at this point?
The fact of the matter is, cardiology is already taking these steps. The new generation of pacemakers has embedded sensors to monitor a patient’s blood temperature, sinus node rate, breathing, and other vitals. This data is used to flexibly alter the heart rate, slowing or speeding it depending on a patient’s current activity level. They also inherited remote control from their predecessors. Practically, next-gen pacemakers are IoT devices.
Accordingly, the industry can either stigmatize the security concerns or choose to adopt a new perspective, seeing the pacemaker crisis as an opportunity to create a solid platform for unbiased adoption of upcoming connected cardiac devices.Continue reading…
By JESSICA DA MASSA, WTF HEALTH
With the application deadline for Bayer’s G4A Partnerships program coming up on Friday, I thought I’d throw out a little inspiration to would-be applicants by featuring an interview I did with one of last year’s program participants at the grand-finale Launch Event.
Not only was this a great party, but a microcosm of the G4A program experience itself: a way to meet Bayer execs en-masse, an opportunity to sell directly to key decision-makers across Bayer’s various global business units, and a chance to feed off the energy of like-minded innovators eager to see ‘big health care’ change for the better.
While the G4A program itself has changed a bit this year to be more streamlined and to allow for bespoke deal-making that may or may not involve giving up equity (my favorite new feature), startups questioning whether or not they have what it takes should take a look at some alums.
There’s a playlist with nearly two dozen interviews waiting for you here if you’re REALLY up for some procrastinating, or you can click through and just check out my chat with Joe Curcio, CEO of KinAptic. A healthtech startup taking wearables to the bleeding edge, Joe shows us a mock-up of the KinAptic ‘smart shirt’ which features their real innovation: printed ink electronics that look and feel like screenprinting ink, but work bi-directionally to both collect data from the body AND apply signals back to it. Is it AI-enabled? Did you have to ask? Listen in for a mindblowing chat about how this tech can change diagnostic analysis and treatment and completely redefine our current limitations when it comes to healthcare wearables.Once you’re inspired, don’t forget to head over to www.g4a.health and fill out your own application for this year’s partnership program.
Jessica DaMassa is the host of the WTF Health show & stars in Health in 2 Point 00 with Matthew Holt
By SHAHID SHAH, MSc and BRIAN VAN WINKLE, MBA
Start-ups are an increasingly important “node” within the healthcare ecosystem. They are challenging status quo concepts that have long been ingrained in the healthcare system, like questioning the value of traditional EMR systems, or shifting the power of information to patients, or breaking down cost and quality transparency barriers. They may be the future of the industry, but startups have a long way to go to truly transform the system. The reasons are many, from an incredibly convoluted and bureaucratic review process and rigid risk-controlling regulations and policies, to the large-scale organizational inertia most of our healthcare systems have.
And while all of these hurdles can and will be overcome if we work together, there are still several lessons each “node” in the ecosystem can learn to more effectively work with each other.
This article is directed at the emerging digital solutions trying resiliently to help transform this stubborn industry. It provides some critical lessons in dealing with healthcare systems and is accompanied by reactions from a digital solutions expert with serial digital health entrepreneurship experience. We hope to provide perspective from two people living and breathing, and surviving, from both sides of the equation every day.
Perspectives and Reactions from the Industry
Healthcare Startups Must Understand how Provider Systems Operate: Most health systems are increasingly becoming rightfully skeptical about new solutions because they feel the solutions don’t understand the environment of their system. To help overcome the challenges of introducing your innovation into a complex business and clinical environment, startups must understand how health systems operate to include how they make decisions, contract and evaluate solutions.
(1) Recognize that Decisions are Consensus-driven and Permissions-based: Unlike other industries, where “shadow IT” is rampant and there can be one or two “key decision makers,” in health systems you’re not likely to get very far without figuring out how to build consensus among an array of influencers and then figuring out how to get permissions from a group of key decision makers. You should seek a “Sherpa” that understands enough about your solution to champion the idea of change – which is really what you’re seeking when you’re selling a new solution (the solution is just the means to accomplish the change, it’s the change that’s hard). The first thing to focus on is to identify the group of decision makers and how you convince them that the status quo should be abandoned in favor of any change – then, once you know how to convince them of some change you’ll work with the group to get the right permissions to work on the change management process – which will then influence a purchase of your solution.
By MATTHEW HOLT
Apparently, podcasts are new, all the rage and minting billionaires every day! So, of course, THCB had to have its own podcast, and here it is: HardCore Health
Now I’ve been doing “podcasts” (otherwise known as audio or video interviews) on THCB since before people actually had iPods (remember those, kids?). But apparently these days any punter can do an interview, call it a podcast and shove it up on Spotify. Hardcore Health is going to be a little bit different…
Hardcore Health will feature multiple guests, topics, and interludes brought to you by many co-hosts starting off with Jessica DaMassa and me. We’ll embed some (familiar) tidbits into the show including: Health in 2 Point 00, THCB Spotlights, and the WTF Health Show as well as some newer segments, including banter sessions between guests & rant sessions from health care experts. This first episode features Brian Kalis, Accenture’s “post” Digital Health expert & Niko Skievaski from Redox, and a little more.
I hope you enjoy our first episode below!
Matthew Holt is the founder and publisher of The Health Care Blog and still writes regularly for the site.
Calling All Tech Companies & Early Stage Innovators Health 2.0 Annual Conference Applications Are Open!
By IRENA LUO
Considered a major hallmark of the Health 2.0 Annual Conference, these two opportunities for tech presentations are a chance for entrepreneurs and startups to gain visibility for their products with potential investors, partners and peers. The conference—scheduled from September 16–18 in Santa Clara, California—is now accepting applications from companies who want to demo their health tech innovations or pitch for a chance to be named Startup Champion at the HIMSS event.
Applications close June 7, 2019
Last year at the 2018 Health 2.0 Annual Conference, more than 100 innovative companies, including Aaptiv, Healthify, and Heart Flow, showcased products designed to help transform healthcare. In 2019, the Health 2.0 team is changing things up and reworking their breakout session schedule to allow more focus around the main stage programming. What does this mean for our demos? With more streamlined programming, we’re upping the ante for our tech demo applicants and selecting the most intriguing, adaptable, applicable products to be featured at the 13th year of the conference. Chosen companies will either demo their tech in standalone presentations or as part of larger panel sessions.
How to apply:
- Go to the application page
- Create a login
- Click “Health 2.0 Live Demos 2019”
Applications close July 8, 2019
For startups and entrepreneurs, the rapid-fire pitch competition is an opportunity to get valuable exposure for their products, make connections with some of health tech’s biggest and most active investors, and ultimately win the title of Most Fundable Startup. Last year, 60 companies competed in the competition. Mira and Avhana Health won in the contest’s consumer and provider tracks, respectively.
The Health 2.0 VentureConnect Pitch competition brings together vetted seed companies through raising Series A companies to pitch their innovative product live on stage during rapid-fire presentations. The prize? Being named the most promising startup by the venture capitalists and corporate investors judging the competition. Six competition finalists—three consumer-facing startups and three provider-facing ones—will compete to win in their category.
How to apply:
- Go to the application page
- Create a login
- Click “Health 2.0 Pitch Competition 2019”
Irena Luo is a Producer at the Health 2.0 Annual Conference, A HIMSS Event
Accenture’s Brian Kalis, catches us up to speed on some of the survey work and analysis the consulting giant has been working on. In particular, Accenture is seeing a generational divide amongst Baby Boomers & the Millennials/Generation Z’s, the latter of which want to consume health care in both traditional & non-traditional ways – a hybrid of technology and older models of care.
For more watch Matthew’s interview with Brian above.
Deven McGraw is one of America’s best known health privacy lawyers, including a stint at HHS running the Office of Civil Rights. But now she’s a cool startup kid living in Silicon Valley and is the Chief Regulatory Officer at Ciitizen. Ciitizen is focusing on helping people collecting, organizing, and securely sharing their personal health data to improve their care, and was founded by Anil Sethi who previously founded Glimpse and sold it to Apple (where it is now the core of Apple’s Health records product).
For more details, watch Matthew’s interview with Deven below.
Arcadia.io is a population health company that helps providers and insurers in their transition to a value-based care model. Arcadia is working with several of the Blues, Cigna, Beth Israel, and more. While it started as a consulting firm, in recent years Arcadia has raised over $40m from Merck, GE, and other corporate venture funds.
Listen to Matthew Holt’s interview with Sean Carroll, CEO of Arcadia.io below.
Today, we’ve got another episode of Health in 2 Point 00—airport edition. On Episode 78, Jess is spending the last few moments before her vacation interviewing me from the airport. She asks me about lots of big raises: Redox raised $33 million for their interoperability platform; EverlyWell, which offers direct-to-consumer lab testing, raised $50 million, and Ro raised another $85 million just a year after raising $88 million. In other news, SureScripts is getting sued by the FDIC for monopolizing the e-prescriptions market and the FBI just raided uBiome for double-billing insurers. —Matthew Holt